Life Sciences Tools & Services

In a recent research report, Piper Jaffray explained why it will maintain its Underweight rating on Luminex Corporation (NASDAQ: LMNX) after the company saw 16.2% yoy revenue growth. “Management anticipates little 2012 impact from the initiatives underway to curb code stacking for molecular...

MFC Industrial Ltd. (NYSE: MIL) announces that its Board of Directors has declared an annual cash dividend for 2012 of US$0.22 per common share. The dividend is 10% higher than the dividend paid in 2011, and, based on the closing price of $7.01 for the Company's common shares on December 31, 2011...

JP Morgan has downgraded Luminex (NASDAQ: LMNX) from Neutral to Underweight and maintains its $18 price target in a research report published today. In the report, JP Morgan writies, "Given management 3Q commentary for more modest consumable growth in 2012, which was a significant source of top...

MFC Industrial Ltd. (NYSE: MIL) today announces that it has acquired, together with its partner in the project, the troubled Pea Ridge Iron Ore Mine located in Sullivan, Missouri, USA. There were numerous contractual disputes and lawsuits with the previous owners of the mine, which have now been...

JP Morgan has downgraded Luminex (NASDAQ: LMNX) from Neutral to Underweight and maintains its $18 price target.

MFC Industrial Ltd. (NYSE: MIL) announced today a filing in Canada and available for inspection at www.sedar.com or www.sedi.ca, that details insider purchases of MIL shares on the open market by Chairman & CEO Michael Smith. There were two trades totaling 180,000 shares: 87,000 shares...

A report from D.I. reiterates its Medium Risk Positive Bias rating on Luminex (NASDAQ: LMNX). The report states, “Concentrated revenue supports our opinion of a Medium Risk - Positive Bias rating for LMNX. In 2010, One Lambda and Bio-Rad Laboratories accounted for 16% and 13% of total revenue,...

J.P. Morgan is out with its report today on Luminex (NASDAQ: LMNX), maintaining Neutral. In its report, J.P. Morgan writes, "LMNX continues to trade at a premium valuation (on either P/Sales or P/E) to peers, and we see limited room for multiple expansion, with the potential for a slowdown in bulk...

Pre-open movers US stock futures are lower this morning, as investors are awaiting consumer confidence data and the minutes of the recent Federal Open Market Committee. Futures for the Dow Jones Industrial Average dipped 49 points to 11,468.00 and S&P 500 index futures fell 6.30 points to 1,201...

ICON plc, (NASDAQ: ICLR) today announced that it has been chosen by Bristol-Myers Squibb Company (NYSE: BMY) as a preferred provider for full-service clinical pharmacology and exploratory clinical studies. This latest agreement with Bristol-Myers-Squibb follows the company's selection of ICON to...